Kayitalire Louis 4
4 · F-star Therapeutics, Inc. · Filed Jan 11, 2022
Insider Transaction Report
Form 4
Kayitalire Louis
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-09+53,634→ 53,634 totalExercise: $4.77Exp: 2032-01-09→ Common Stock (53,634 underlying)
Footnotes (2)
- [F1]These options were granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]Twenty five percent (25%) of the total number of shares under the award shall vest on the first anniversary of the Vesting Commencement Date, January 9, 2022, and thereafter in 36 equal monthly installments such that the stock option shall be fully-vested on the fourth annual anniversary of the Vesting Commencement Date.